Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Galderma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (50)
Cancellation by sponsor (47)
Australian Public Assessment Report (AusPAR) (5)
Prescription medicine decision summary (1)
Prescription medicine evaluation (1)
Prescription medicine registration (1)

Date

2024 (3)
2023 (6)
2021 (12)
2020 (4)
2019 (13)
2018 (7)
2017 (21)
2016 (2)
2015 (10)
2014 (2)
2013 (5)
2012 (1)
2010 (3)
2009 (1)
2006 (1)
2004 (1)
2003 (1)
2002 (1)
1998 (4)
1996 (1)
1995 (2)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

105 result(s) found, displaying 11 to 20

AKLIEF trifarotene 50 microgram/g cream bottle (332220)

18 January 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AKLIEF trifarotene 50 microgram/g cream bottle.
Galderma Australia Pty Ltd - Soap, skin, liquid (340806)

4 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Galderma Australia Pty Ltd - Soap, skin, liquid.
METROGEL metronidazole 7.5mg/g gel tube Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane SubQ Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane Skinboosters Vital - Dermal tissue reconstructive material, microbe-derived Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane SubQ - Tissue reconstructive material, synthetic, fluid Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane Lyft - Dermal tissue reconstructive material, microbe-derived Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane - Tissue reconstructive material, synthetic, fluid Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
AusPAR: Trifarotene

18 March 2021

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Trifarotene
Cetaphil Dermacontrol Cancelled under Section 30(1)(c) of the Act

8 February 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.